Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Oesophageal squamous cell carcinoma, drawn from the whole corpus: 17 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Whether surgery can be omitted after a complete response to chemoradiation.
Most cases worldwide present late without access to endoscopy.
Nothing recorded yet.
Nothing recorded yet.
Also on OnCo: Financial help · Coverage by country · HTA decisions.
Nutrition, swallowing and quality of life during and after treatment.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 14 changes by month →When this page itself was last checked or edited.
First-line ESCC PD-L1 ≥1% (RATIONALE-306)
First-line ESCC, PD-L1 ≥1%, with platinum chemotherapy
Second-line ESCC (RATIONALE-302)
Second-line ESCC after chemotherapy; first-line HER2-negative gastric/GEJ with chemotherapy (PD-L1 ≥1)
A milestone in how this cancer is treated.